THIS WEEK'S FEATURE
Features
Past Features
Featured
Canopy Health Innovations, the research subsidiary of Canopy Growth (TSX:WEED; NYSE:CGC) that focuses on the development of therapeutic and natural health cannabis products, will get a big boost from a blockbuster $5-billion (Canadian) investment by Constellation Brands (NYSE:STZ) in Canopy Growth, a world-leading diversified cannabis and hemp company.
Closely-held Zuga Medical expects to roll out its digital dental implant solution, known as ZugaLink, across the U.S. in 2019.
Closely-held Penta Medical is now on the sales and marketing trail, targeting sports teams, orthopedic doctors and physical therapists with its PentaVO device. The wearable cold laser therapy and data collection device received FDA approval in July for the improvement of circulation and the reduction of joint pain and stiffness.
TRACON Pharmaceuticals (NASDAQ:TCON) is expected to report several important potential milestones over the next two quarters, including two randomized data points from its product development pipeline.
Dr. Robert Foster is teeing up another possible home run as the new CEO of ContraVir Pharmaceuticals (NASDAQ:CTRV) and its lead programs for liver disease arising from chronic viral infection and NASH (non-alcoholic steatohepatitis). He joined ContraVir as CSO in 2016 after the company acquired his startup, Ciclofilin Pharmaceuticals.
